Suicide Risk and the COVID-19 Pandemic: Transforming Threat to Skills for Safer Living
2021-04-29 @ 12:00 pm – 1:00 pm
Sakina Rizvi, PhD Scientist, St. Michael’s Hospital
Assistant Professor of Psychiatry, University of Toronto. Dr. Sakina Rizvi’s research expertise spans neuroimaging, psychotherapy, and pharmacology; with a focus in Major Depressive Disorder. Her research aims to characterize the neurobiology of suicide risk and treatment resistant depression, primarily through the use of brain imaging, and to develop and test novel psychotherapeutic strategies. In addition to her research, Dr. Rizvi is actively involved in outreach and advocacy projects with an emphasis on providing mental health education to the community through the creative arts.
Aleksandra Lalovic, MSc, MEd, RP
Research Psychotherapist, St. Michael’s Hospital. Aleksandra Lalovic is a Research Psychotherapist in the ASR Program. She is involved in several studies investigating innovative psychotherapeutic approaches to help people who experience suicidal ideation and behaviour. She is a Registered Psychotherapist with the College of Registered Psychotherapists of Ontario (CRPO). Aleksandra completed her clinical training at University of Toronto’s OISE Counselling Psychology program. She also holds a research doctorate in Neuroscience from McGill University, where she studied the neurobiology and genetics of depression and suicide risk.
- Recognize the impacts of the COVID-19 pandemic on suicide risk.
- Gain insights from biopsychosocial research about suicide.
- Become informed of strategies that can help support individuals with
possible suicide risk.